Managers / Q2 2023 · view latest →
HFR Wealth Management, LLC
CIK 0001877822 · 1760 VAN ANTWERP ROAD, NISKAYUNA, NY, 12309 · 5183468189
Summary
Hfr Wealth Management, LLC reported $359,587 in U.S.-listed holdings across 55 positions for Q2 2023.
Its largest position, AAPL, represents 5.4% of the portfolio.
Compared with Q1 2023, the fund opened 1 new position and exited 7.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 97.2% · $349,462
- Other · 2.6% · $9,281
- ETP · 0.2% · $844
Quarter-over-Quarter Changes full breakdown →
vs Q1 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| HONGBPHONEYWELL INTL INC | NEW | +1.0K | 1.0K | +$208 | $208 |
| NVDANVIDIA CORPORATION | SOLD OUT | −4.0K | 0 | −$1,111 | $0 |
| BABOEING CO | SOLD OUT | −1.3K | 0 | −$278 | $0 |
| FFORD MTR CO DEL | SOLD OUT | −20.0K | 0 | −$252 | $0 |
| LUVSOUTHWEST AIRLS CO | SOLD OUT | −7.5K | 0 | −$244 | $0 |
| CATCATERPILLAR INC DEL | SOLD OUT | −1.0K | 0 | −$229 | $0 |
| SRSPIRE INC | SOLD OUT | −3.0K | 0 | −$214 | $0 |
| VNDAVANDA PHARMACEUTICALS INC | SOLD OUT | −20.0K | 0 | −$136 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $407M | 49 | May 4, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $424M | 50 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $436M | 51 | Nov 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $414M | 51 | Aug 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $411M | 53 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $405M | 52 | Feb 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $412M | 54 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $393M | 53 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | Under review | 55 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $368,918 | 53 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $341,676 | 52 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $359,587 | 55 | Aug 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $352,257 | 61 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 63 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $307M | 53 | Nov 7, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $331M | 60 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $378M | 61 | May 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $398M | 64 | Feb 7, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $343M | 59 | Nov 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $332M | 58 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.